Need help finding what you are looking for?
Contact Us
PUBLISHER: The Insight Partners | PRODUCT CODE: 1874005
PUBLISHER: The Insight Partners | PRODUCT CODE: 1874005
Cell Therapy Instrument Market
PUBLISHED:
PAGES: 150 Pages
DELIVERY TIME: 1-5 business days
SELECT AN OPTION
The market for cell therapy instruments was valued at approximately US$ 23.28 billion in 2024 and is projected to grow to around US$ 59.98 billion by 2031. This market is anticipated to experience a compound annual growth rate (CAGR) of 15.4% from 2031 to 2031, with a significant trend towards automated manufacturing in cell therapy instruments.
Analysis of the Cell Therapy Instrument Market
Cell therapy involves the injection, implantation, or grafting of living cells into a patient's body. For example, during immunotherapy, a cancer patient may receive T cell injections. The delivery methods for cell therapy instruments vary from simple injections to complex surgical implantations using specialized devices. Cell therapy is applicable to a wide range of conditions, with cancer being one of the most critical diseases affecting the nervous system. Other applications include cardiac issues (such as myocardial infarction and heart failure), diabetes, musculoskeletal disorders, genetic diseases, and skin and soft tissue wounds.
Overview of the Cell Therapy Instrument Market
Chimeric antigen receptor (CAR) T-cell therapy is one of the most promising cancer treatment methods, with numerous pre-clinical and clinical trials conducted annually to broaden its applications. After years of research, CAR-T cell therapy is set to expand further. Future developments will explore not only autologous and allogeneic products but also new in-vivo CAR-T cell gene therapies and their effectiveness in conditions beyond hematologic malignancies.
Strategic Insights
Drivers and Opportunities in the Cell Therapy Instrument Market
Advancements in Cell Therapy Manufacturing
Growing research in cell therapy has led to remarkable advancements in cell therapy instruments aimed at treating genetic disorders and enhancing immune responses. Various companies provide essential consumables like reagent kits and enzymes, while others offer the necessary instruments, equipment, and software for a wide array of cell therapy processes.
The use of specialized equipment is crucial for producing cell therapies such as T cells, hematopoietic stem cells (HSC), mesenchymal stem cells (MSC), pluripotent stem cells (PSC), and neural stem cells (NSC). Since these products are derived from human or animal cells, maintaining contamination-free conditions is vital. Consequently, the instruments used in cell therapies are designed to prevent contamination and facilitate increased production. Notable companies like Corning Incorporated, Hitachi Chemical Advanced Therapeutics Solutions, LLC, Cytiva (a General Electric Company), Thermo Fisher Scientific Inc., Invetech, and Miltenyi Biotec have developed various instruments and consumables for cell therapy applications.
The biotechnology industry in the Asia Pacific and Middle East regions is rapidly expanding, bolstered by significant investments and strategic initiatives from both private and public sectors, particularly in comparison to North America and Europe. For example, in December 2024, Astellas Pharma Inc. from Japan announced its acquisition of Audentes Therapeutics Inc., a gene therapy firm, for US$ 3 billion. Similarly, in November 2024, Fujifilm revealed plans to invest approximately US$ 120 million (13 billion yen) in gene therapy as part of its contract development and manufacturing segment. Additionally, the Japan Pharmaceutical Medical Device Agency (PMDA) approved two gene therapy products under the Sakigake designation, which is akin to the FDA's breakthrough therapy designation and the EMA's Priority Medicine (PRIME) designation, with expectations to approve at least one therapy annually. Such strategic moves by domestic players in Asian countries are likely to drive demand for cell therapy instruments in the near future.
Segmentation Analysis of the Cell Therapy Instrument Market
The analysis of the cell therapy instrument market is segmented by disorder and service providers.
- The market is categorized by products into consumables, equipment, systems, and software, with the consumables segment holding the largest market share in 2023.
- By cell type, the market is divided into human cells and animal cells, with thermoplastics representing the largest market share in 2023.
- By process, the market is segmented into cell processing, process monitoring and quality control, cell preservation, distribution, and handling, with the cell processing segment leading in market share in 2023.
- By end users, the market is categorized into research institutes, life science research companies, and other end users, with life science research companies holding the largest market share in 2023.
Geographical Analysis of the Cell Therapy Instrument Market
The geographical scope of the cell therapy instrument market report is divided into five regions: North America, Asia Pacific, Europe, Middle East & Africa, and South America/South & Central America.
The United States stands out as the largest and fastest-growing market for cell therapy instruments, driven by increased research and development and the rising adoption of cell therapies, including gene, stem cell, and immune therapies. Furthermore, government support is significantly contributing to the growth of cell therapies, positively impacting market expansion. For instance, the American Society of Gene & Cell Therapy (ASGCT) is a public organization that offers memberships to scientists, physicians, professionals, and patient advocates involved in gene and cell therapies, aiming to enhance knowledge, education, and awareness regarding the clinical applications of these therapies.
Scope of the Cell Therapy Instrument Market Report
Recent Developments in the Cell Therapy Instrument Market
The evaluation of the cell therapy instrument market is based on qualitative and quantitative data collected through primary and secondary research, including significant corporate publications, association data, and databases. Recent developments in the market include:
- Thermo Fisher Scientific and robotics company Multiply Labs have entered into an agreement to enhance their collaboration in automating cell therapy production. (Source: Thermo Fisher Scientific, 2024).
- MaxCyte has launched the ExPERT instrument family to provide a comprehensive technological platform for next-generation cellular therapies from concept to commercialization. (Source: MaxCyte, Press Release, 2024).
Report Coverage and Deliverables for the Cell Therapy Instrument Market
The report titled "Cell Therapy Instrument Market Size and Forecast (2021-2031)" offers an in-depth analysis of the market, covering the following areas:
- Market size and forecast at global, regional, and country levels for all key market segments included in the scope.
- Market dynamics, including drivers, restraints, and key opportunities.
- Key future trends.
- Comprehensive PEST/Porter's Five Forces and SWOT analysis.
- Global and regional market analysis highlighting key trends, major players, regulations, and recent developments.
- Industry landscape and competition analysis, including market concentration, heat map analysis, prominent players, and recent developments.
- Detailed company profiles.
Product Code: TIPRE00003481
Table Of Contents
1. Introduction
- 1.1 Scope of the Study
- 1.2 The Insight Partners Research Report Guidance
- 1.3 Market Segmentation
- 1.3.1 Cell Therapy Instruments Market and By Product
- 1.3.2 Cell Therapy Instruments Market and By Cell Type
- 1.3.3 Cell Therapy Instruments Market and By Process
- 1.3.4 Cell Therapy Instruments Market and By End User
- 1.3.5 Global Cell Therapy Instruments Market and By Geography
2. Cell Therapy Instruments Market and Key Takeaways
3. Research Methodology
- 3.1 Coverage
- 3.2 Secondary Research
- 3.3 Primary Research
4. Global Cell Therapy Instrumentsand Market Landscape
- 4.1 Overview
- 4.2 PEST Analysis
- 4.2.1 North America and PEST Analysis
- 4.2.2 Europe and PEST Analysis
- 4.2.3 Asia Pacific and PEST Analysis
- 4.2.4 Middle East and Africa (MEA) and PEST Analysis
- 4.2.5 South and Central America (SCAM) and PEST Analysis
- 4.3 Expert Opinions
5. Cell Therapy Instruments Market and Key Market Dynamics
- 5.1 Market Drivers
- 5.1.1 Increasing Developments in Cell Therapy Manufacturing
- 5.1.2 Rising Number of Approvals for Cell-based Therapies
- 5.2 Market Restraints
- 5.2.1 High Cost Of Cell Therapy Production and Cell Therapy
- 5.3 Market Opportunities
- 5.3.1 Growth Opportunities in Developing Regions
- 5.4 Future Trends
- 5.4.1 Shift Toward Automated Manufacturing
- 5.5 Impact Analysis
6. Cell Therapy Instruments Market and Global Analysis
- 6.1 Global Cell Therapy Instrument Marker Revenue Forecast And Analysis
- 6.2 Global Cell Therapy Instruments Market, By Geography - Forecast And Analysis
- 6.3 Market Positioning of Key Players
7. Cell Therapy Instruments Market Analysis and By Product
- 7.1 Overview
- 7.2 Cell Therapy Instruments Market Revenue Share, by Product (2024 and 2031)
- 7.3 Consumables
- 7.3.1 Overview
- 7.3.2 Consumables: Cell Therapy Instruments Market and Revenue and Forecast to 2031 (US$ Million)
- 7.4 Equipment
- 7.4.1 Overview
- 7.4.2 Equipment: Cell Therapy Instruments Market and Revenue and Forecast to 2031 (US$ Million)
- 7.4.3 Singleanduse Equipment
- 7.4.3.1 Overview
- 7.4.3.2 Singleanduse Equipment: Cell Therapy Instruments Market and Revenue and Forecast to 2031 (US$ Million)
- 7.4.4 Cell Processing Equipment
- 7.4.4.1 Overview
- 7.4.4.2 Cell Processing Equipment: Cell Therapy Instruments Market and Revenue and Forecast to 2031 (US$ Million)
- 7.4.5 Other Equipment
- 7.4.5.1 Overview
- 7.4.5.2 Other Equipment: Cell Therapy Instruments Market and Revenue and Forecast to 2031 (US$ Million)
- 7.5 Systems and Software
- 7.5.1 Overview
- 7.5.2 Systems and Software Segment: Cell Therapy Instruments Market and Revenue and Forecast to 2031 (US$ Million)
8. Cell Therapy Instruments Market Analysis and By Cell Type
- 8.1 Overview
- 8.2 Cell Therapy Instruments Market Revenue Share, by Cell Type (2024 and 2031)
- 8.3 Human Cells
- 8.3.1 Human Cells: Cell Therapy Instruments Market and Revenue and Forecast to 2031 (US$ Million)
- 8.3.2 Differentiated Cells
- 8.3.2.1 Overview
- 8.3.2.2 Differentiated Cells: Cell Therapy Instruments Market and Revenue and Forecast to 2031 (US$ Million)
- 8.3.3 Stem Cells
- 8.3.3.1 Overview
- 8.3.3.2 Stem Cells: Cell Therapy Instruments Market and Revenue and Forecast to 2031 (US$ Million)
- 8.4 Animal Cells
- 8.4.1 Overview
- 8.4.2 Animal Cells : Cell Therapy Instruments Market and Revenue and Forecast to 2031 (US$ Million)
9. Cell Therapy Instruments Market Analysis and By Process
- 9.1 Overview
- 9.2 Cell Therapy Instruments Market Revenue Share, by Process (2024 and 2031)
- 9.3 Cell Processing
- 9.3.1 Cell Processing: Cell Therapy Instruments Market and Revenue and Forecast to 2031 (US$ Million)
- 9.4 Process Monitoring and Quality Control
- 9.4.1 Process Monitoring and Quality Control: Cell Therapy Instruments Market and Revenue and Forecast to 2031 (US$ Million)
- 9.5 Cell Preservation, Distribution, and Handling
- 9.5.1 Cell Preservation, Distribution, and Handling: Cell Therapy Instruments Market and Revenue and Forecast to 2031 (US$ Million)
10. Cell Therapy Instruments Market Analysis and By End User
- 10.1 Overview
- 10.2 Cell Therapy Instruments Market Share, by End Users, 2024 and 2031, (%)
- 10.3 Research Institutes
- 10.3.1 Overview
- 10.3.2 Research Institutes: Cell Therapy Instruments Market and Revenue and Forecast to 2031 (US$ Million)
- 10.4 Life Science Research Companies
- 10.4.1 Overview
- 10.4.2 Life Science Research Companies : Cell therapy instruments market and Revenue and Forecast to 2031 (US$ Million)
- 10.5 Other End Users
- 10.5.1 Overview
- 10.5.2 Other End Users: Cell therapy instruments market and Revenue and Forecast to 2031 (US$ Million)
11. Cell Therapy Instruments Market Analysis And Forecast to 2031 and Geographical Analysis
- 11.1 North America: Cell Therapy Instruments Market
- 11.1.1 Overview
- 11.1.2 North America: Cell Therapy Instruments Market,- Revenue and Forecast to 2031 (USD Million)
- 11.1.3 North America: Cell Therapy Instruments Market, by Product and Revenue and Forecast to 2031 (USD Million)
- 11.1.3.1 North America: Equipment Market, by Type and Revenue and Forecast to 2031 (USD Million)
- 11.1.4 North America: Cell Therapy Instruments Market, by Cell Type and Revenue and Forecast to 2031 (USD Million)
- 11.1.4.1 North America: Human Cells Market, by Type and Revenue and Forecast to 2031 (USD Million)
- 11.1.5 North America: Cell Therapy Instruments Market, by Process and Revenue and Forecast to 2031 (USD Million)
- 11.1.6 North America: Cell Therapy Instruments Market, by End User and Revenue and Forecast to 2031 (USD Million)
- 11.1.7 North America: Cell Therapy Instruments Market, by Country, 2024 and 2031 (%)
- 11.1.8 US: Cell Therapy Instruments Market and Revenue and Forecast to 2031 (USD Million)
- 11.1.8.1 US: Cell Therapy Instruments Market and Revenue and Forecast to 2031 (USD Million)
- 11.1.8.2 US: Cell Therapy Instruments Market, by Product and Revenue and Forecast to 2031 (USD Million)
- 11.1.8.2.1 US: Equipment Market,, by Type and Revenue and Forecast to 2031 (USD Million)
- 11.1.8.3 US: Cell Therapy Instruments Market, by Cell Type and Revenue and Forecast to 2031 (USD Million)
- 11.1.8.3.1 US: Human Cells Market, by Type and Revenue and Forecast to 2031 (USD Million)
- 11.1.8.4 US: Cell Therapy Instruments Market, by Process and Revenue and Forecast to 2031 (USD Million)
- 11.1.8.5 US: Cell Therapy Instruments Market, by End User and Revenue and Forecast to 2031 (USD Million)
- 11.1.9 Canada: Cell Therapy Instruments Market and Revenue and Forecast to 2031 (USD Million)
- 11.1.9.1 Canada: Cell Therapy Instruments Market and Revenue and Forecast to 2031 (USD Million)
- 11.1.9.2 Canada: Cell Therapy Instruments Market, by Product and Revenue and Forecast to 2031 (USD Million)
- 11.1.9.2.1 Canada: Equipment Market,, by Type and Revenue and Forecast to 2031 (USD Million)
- 11.1.9.3 Canada: Cell Therapy Instruments Market, by Cell Type and Revenue and Forecast to 2031 (USD Million)
- 11.1.9.3.1 Canada: Human Cells Market,, by Type and Revenue and Forecast to 2031 (USD Million)
- 11.1.9.4 Canada: Cell Therapy Instruments Market, by Process and Revenue and Forecast to 2031 (USD Million)
- 11.1.9.5 Canada: Cell Therapy Instruments Market, by End User and Revenue and Forecast to 2031 (USD Million)
- 11.1.10 Mexico: Cell Therapy Instruments Market and Revenue and Forecast to 2031 (USD Million)
- 11.1.10.1 Mexico: Cell Therapy Instruments Market and Revenue and Forecast to 2031 (USD Million)
- 11.1.10.2 Mexico: Cell Therapy Instruments Market, by Product and Revenue and Forecast to 2031 (USD Million)
- 11.1.10.2.1 Mexico: Equipment Market,, by Type and Revenue and Forecast to 2031 (USD Million)
- 11.1.10.3 Mexico: Cell Therapy Instruments Market, by Cell Type and Revenue and Forecast to 2031 (USD Million)
- 11.1.10.3.1 Mexico: Human Cells Market,, by Type and Revenue and Forecast to 2031 (USD Million)
- 11.1.10.4 Mexico: Cell Therapy Instruments Market, by Process and Revenue and Forecast to 2031 (USD Million)
- 11.1.10.5 Mexico: Cell Therapy Instruments Market, by End User and Revenue and Forecast to 2031 (USD Million)
- 11.2 Europe: Cell Therapy Instruments Market
- 11.2.1 Overview
- 11.2.2 Europe: Cell Therapy Instruments Market - Revenue and Forecast to 2031 (USD Million)
- 11.2.3 Europe: Cell Therapy Instruments Market, by Product, 2024 and 2031 (USD Millions)
- 11.2.3.1 Europe: Equipment Market, by Type, 2024 and 2031 (USD Millions)
- 11.2.4 Europe: Cell Therapy Instruments Market, by Cell Type, 2024 and 2031 (USD Million)
- 11.2.4.1 Europe: Human Cells Market, by Type, 2024 and 2031 (USD Million)
- 11.2.5 Europe: Cell Therapy Instruments Market, by Process, 2024 and 2031 (USD Million)
- 11.2.6 Europe: Cell Therapy Instruments Market, by End User, 2024 and 2031 (USD Million)
- 11.2.7 Europe: Cell Therapy Instruments Market, by Country, 2019 and 2031 (%)
- 11.2.8 Germany: Cell Therapy Instruments Market and Revenue and Forecast to 2031 (USD Million)
- 11.2.8.1 Germany: Cell Therapy Instruments Market and Revenue and Forecast to 2031 (USD Million)
- 11.2.8.2 Germany: Cell Therapy Instruments Market, by Product, 2024 and 2031 (USD Millions)
- 11.2.8.2.1 Germany: Equipment Market, by Type, 2024 and 2031 (USD Millions)
- 11.2.8.3 Germany: Cell Therapy Instruments Market, by Cell Type, 2024 and 2031 (USD Million)
- 11.2.8.3.1 Germany: Human Cells Market, by Type, 2024 and 2031 (USD Million)
- 11.2.8.4 Germany: Cell Therapy Instruments Market, by Process, 2024 and 2031 (USD Million)
- 11.2.8.5 Germany: Cell Therapy Instruments Market, by End User, 2024 and 2031 (USD Million)
- 11.2.9 France: Cell Therapy Instruments Market and Revenue and Forecast to 2031 (USD Million)
- 11.2.9.1 France: Cell Therapy Instruments Market and Revenue and Forecast to 2031 (USD Million)
- 11.2.9.2 France: Cell Therapy Instruments Market, by Product, 2024 and 2031 (USD Millions)
- 11.2.9.2.1 France: Equipment Market, by Type, 2024 and 2031 (USD Millions)
- 11.2.9.3 France: Cell Therapy Instruments Market, by Cell Type, 2024 and 2031 (USD Million)
- 11.2.9.3.1 France: Human Cells Market, by Type, 2024 and 2031 (USD Million)
- 11.2.9.4 France: Cell Therapy Instruments Market, by Process, 2024 and 2031 (USD Million)
- 11.2.9.5 France: Cell Therapy Instruments Market, by End User, 2024 and 2031 (USD Million)
- 11.2.10 UK: Cell Therapy Instruments Market and Revenue and Forecast to 2031 (USD Million)
- 11.2.10.1 UK: Cell Therapy Instruments Market and Revenue and Forecast to 2031 (USD Million)
- 11.2.10.2 UK: Cell Therapy Instruments Market, by Product, 2024 and 2031 (USD Millions)
- 11.2.10.2.1 UK: Equipment Market, by Type, 2024 and 2031 (USD Millions)
- 11.2.10.3 UK: Cell Therapy Instruments Market, by Cell Type, 2024 and 2031 (USD Million)
- 11.2.10.3.1 UK: Human Cells Market, by Type, 2024 and 2031 (USD Million)
- 11.2.10.4 UK: Cell Therapy Instruments Market, by Process, 2024 and 2031 (USD Million)
- 11.2.10.5 UK: Cell Therapy Instruments Market, by End User, 2024 and 2031 (USD Million)
- 11.2.11 Italy: Cell Therapy Instruments Market and Revenue and Forecast to 2031 (USD Million)
- 11.2.11.1 Italy: Cell Therapy Instruments Market and Revenue and Forecast to 2031 (USD Million)
- 11.2.11.2 Italy: Cell Therapy Instruments Market, by Product, 2024 and 2031 (USD Millions)
- 11.2.11.2.1 Italy: Equipment Market, by Type, 2024 and 2031 (USD Millions)
- 11.2.11.3 Italy: Cell Therapy Instruments Market, by Cell Type, 2024 and 2031 (USD Million)
- 11.2.11.3.1 Italy: Human Cells Market, by Type, 2024 and 2031 (USD Million)
- 11.2.11.4 Italy: Cell Therapy Instruments Market, by Process, 2024 and 2031 (USD Million)
- 11.2.11.5 Italy: Cell Therapy Instruments Market, by End User, 2024 and 2031 (USD Million)
- 11.2.12 Spain: Cell Therapy Instruments Market and Revenue and Forecast to 2031 (USD Million)
- 11.2.12.1 Spain: Cell Therapy Instruments Market and Revenue and Forecast to 2031 (USD Million)
- 11.2.12.2 Spain: Cell Therapy Instruments Market, by Product, 2024 and 2031 (USD Millions)
- 11.2.12.2.1 Spain: Equipment Market, by Type, 2024 and 2031 (USD Millions)
- 11.2.12.3 Spain: Cell Therapy Instruments Market, by Cell Type, 2024 and 2031 (USD Million)
- 11.2.12.3.1 Spain: Human Cells Market, by Type, 2024 and 2031 (USD Million)
- 11.2.12.4 Spain: Cell Therapy Instruments Market, by Process, 2024 and 2031 (USD Million)
- 11.2.12.5 Spain: Cell Therapy Instruments Market, by End User, 2024 and 2031 (USD Million)
- 11.3 Asia Pacific: Cell Therapy Instruments Market
- 11.3.1 Overview
- 11.3.2 Asia Pacific: Cell Therapy Instruments Market - Revenue and Forecast to 2031 (USD Million)
- 11.3.3 Asia Pacific: Cell Therapy Instruments Market, by Product, 2024 and 2031 (USD Millions)
- 11.3.3.1 Asia Pacific: Equipment Market, by Type, 2024 and 2031 (USD Millions)
- 11.3.4 Asia Pacific: Cell Therapy Instruments Market, by Cell Type, 2024 and 2031 (USD Million)
- 11.3.4.1 Asia Pacific: Human Cells Market, by Type, 2024 and 2031 (USD Million)
- 11.3.5 Asia Pacific: Cell Therapy Instruments Market, by Process, 2024 and 2031 (USD Million)
- 11.3.6 Asia Pacific: Cell Therapy Instruments Market, by End User, 2024 and 2031 (USD Million)
- 11.3.7 Asia Pacific: Cell Therapy Instruments Market, by Country, 2019 and 2031 (%)
- 11.3.8 China: Cell Therapy Instruments Market and Revenue and Forecast to 2031 (USD Million)
- 11.3.8.1 China: Cell Therapy Instruments Market and Revenue and Forecast to 2031 (USD Million)
- 11.3.8.2 China: Cell Therapy Instruments Market, by Product, 2024 and 2031 (USD Millions)
- 11.3.8.2.1 China: Equipment Market, by Type, 2024 and 2031 (USD Millions)
- 11.3.8.3 China: Cell Therapy Instruments Market, by Cell Type, 2024 and 2031 (USD Million)
- 11.3.8.3.1 China: Human Cells Market, by Type, 2024 and 2031 (USD Million)
- 11.3.8.4 China: Cell Therapy Instruments Market, by Process, 2024 and 2031 (USD Million)
- 11.3.8.5 China: Cell Therapy Instruments Market, by End User, 2024 and 2031 (USD Million)
- 11.3.9 Japan: Cell Therapy Instruments Market and Revenue and Forecast to 2031 (USD Million)
- 11.3.9.1 Japan: Cell Therapy Instruments Market and Revenue and Forecast to 2031 (USD Million)
- 11.3.9.2 Japan: Cell Therapy Instruments Market, by Product, 2024 and 2031 (USD Millions)
- 11.3.9.2.1 Japan: Equipment Market, by Type, 2024 and 2031 (USD Millions)
- 11.3.9.3 Japan: Cell Therapy Instruments Market, by Cell Type, 2024 and 2031 (USD Million)
- 11.3.9.3.1 Japan: Human Cells Market, by Type, 2024 and 2031 (USD Million)
- 11.3.9.4 Japan: Cell Therapy Instruments Market, by Process, 2024 and 2031 (USD Million)
- 11.3.9.5 Japan: Cell Therapy Instruments Market, by End User, 2024 and 2031 (USD Million)
- 11.3.10 India: Cell Therapy Instruments Market and Revenue and Forecast to 2031 (USD Million)
- 11.3.10.1 India: Cell Therapy Instruments Market and Revenue and Forecast to 2031 (USD Million)
- 11.3.10.2 India: Cell Therapy Instruments Market, by Product, 2024 and 2031 (USD Millions)
- 11.3.10.2.1 India: Equipment Market, by Type, 2024 and 2031 (USD Millions)
- 11.3.10.3 India: Cell Therapy Instruments Market, by Cell Type, 2024 and 2031 (USD Million)
- 11.3.10.3.1 India: Human Cells Market, by Type, 2024 and 2031 (USD Million)
- 11.3.10.4 India: Cell Therapy Instruments Market, by Process, 2024 and 2031 (USD Million)
- 11.3.10.5 India: Cell Therapy Instruments Market, by End User, 2024 and 2031 (USD Million)
- 11.3.11 South Korea: Cell Therapy Instruments Market and Revenue and Forecast to 2031 (USD Million)
- 11.3.11.1 South Korea: Cell Therapy Instruments Market and Revenue and Forecast to 2031 (USD Million)
- 11.3.11.2 South Korea : Cell Therapy Instruments Market, by Product, 2024 and 2031 (USD Millions)
- 11.3.11.2.1 South Korea : Equipment Market, by Type, 2024 and 2031 (USD Millions)
- 11.3.11.3 South Korea : Cell Therapy Instruments Market, by Cell Type, 2024 and 2031 (USD Million)
- 11.3.11.3.1 South Korea : Human Cells Market, by Type, 2024 and 2031 (USD Million)
- 11.3.11.4 South Korea : Cell Therapy Instruments Market, by Process, 2024 and 2031 (USD Million)
- 11.3.11.5 South Korea : Cell Therapy Instruments Market, by End User, 2024 and 2031 (USD Million)
- 11.3.12 Australia: Cell Therapy Instruments Market and Revenue and Forecast to 2031 (USD Million)
- 11.3.12.1 Australia: Cell Therapy Instruments Market and Revenue and Forecast to 2031 (USD Million)
- 11.3.12.2 Australia: Cell Therapy Instruments Market, by Product, 2024 and 2031 (USD Millions)
- 11.3.12.2.1 Australia: Equipment Market, by Type, 2024 and 2031 (USD Millions)
- 11.3.12.3 Australia: Cell Therapy Instruments Market, by Cell Type, 2024 and 2031 (USD Million)
- 11.3.12.3.1 Australia: Human Cells Market, by Type, 2024 and 2031 (USD Million)
- 11.3.12.4 Australia: Cell Therapy Instruments Market, by Process, 2024 and 2031 (USD Million)
- 11.3.12.5 Australia: Cell Therapy Instruments Market, by End User, 2024 and 2031 (USD Million)
- 11.4 Middle East and Africa: Cell Therapy Instruments Market
- 11.4.1 Overview
- 11.4.2 Middle East and Africa: Cell Therapy Instruments Market - Revenue and Forecast to 2031 (USD Million)
- 11.4.3 Middle East and Africa: Cell Therapy Instruments Market, by Product, 2024 and 2031 (USD Millions)
- 11.4.3.1 Middle East and Africa: Equipment Market, by Type, 2024 and 2031 (USD Millions)
- 11.4.4 Middle East and Africa: Cell Therapy Instruments Market, by Cell Type, 2024 and 2031 (USD Million)
- 11.4.4.1 Middle East and Africa: Human Cells Market, by Type, 2024 and 2031 (USD Million)
- 11.4.5 Middle East and Africa: Cell Therapy Instruments Market, by Process, 2024 and 2031 (USD Million)
- 11.4.6 Middle East and Africa: Cell Therapy Instruments Market, by End User, 2024 and 2031 (USD Million)
- 11.4.7 Middle East and Africa: Cell Therapy Instruments Market, by Country, 2019 and 2031 (%)
- 11.4.8 UAE: Cell Therapy Instruments Market and Revenue and Forecast to 2031 (USD Million)
- 11.4.8.1 UAE: Cell Therapy Instruments Market and Revenue and Forecast to 2031 (USD Million)
- 11.4.8.2 UAE: Cell Therapy Instruments Market, by Product, 2024 and 2031 (USD Millions)
- 11.4.8.2.1 UAE: Equipment Market, by Type, 2024 and 2031 (USD Millions)
- 11.4.8.3 UAE: Cell Therapy Instruments Market, by Cell Type, 2024 and 2031 (USD Million)
- 11.4.8.3.1 UAE: Human Cells Market, by Type, 2024 and 2031 (USD Million)
- 11.4.8.4 UAE: Cell Therapy Instruments Market, by Process, 2024 and 2031 (USD Million)
- 11.4.8.5 UAE: Cell Therapy Instruments Market, by End User, 2024 and 2031 (USD Million)
- 11.4.9 Saudi Arabia: Cell Therapy Instruments Market and Revenue and Forecast to 2031 (USD Million)
- 11.4.9.1 Saudi Arabia: Cell Therapy Instruments Market and Revenue and Forecast to 2031 (USD Million)
- 11.4.9.2 Saudi Arabia: Cell Therapy Instruments Market, by Product, 2024 and 2031 (USD Millions)
- 11.4.9.2.1 Saudi Arabia: Equipment Market, by Type, 2024 and 2031 (USD Millions)
- 11.4.9.3 Saudi Arabia: Cell Therapy Instruments Market, by Cell Type, 2024 and 2031 (USD Million)
- 11.4.9.3.1 Saudi Arabia: Human Cells Market, by Type, 2024 and 2031 (USD Million)
- 11.4.9.4 Saudi Arabia: Cell Therapy Instruments Market, by Process, 2024 and 2031 (USD Million)
- 11.4.9.5 Saudi Arabia: Cell Therapy Instruments Market, by End User, 2024 and 2031 (USD Million)
- 11.4.10 South Africa: Cell Therapy Instruments Market and Revenue and Forecast to 2031 (USD Million)
- 11.4.10.1 South Africa: Cell Therapy Instruments Market and Revenue and Forecast to 2031 (USD Million)
- 11.4.10.2 South Africa: Cell Therapy Instruments Market, by Product, 2024 and 2031 (USD Millions)
- 11.4.10.2.1 South Africa: Equipment Market, by Type, 2024 and 2031 (USD Millions)
- 11.4.10.3 South Africa: Cell Therapy Instruments Market, by Cell Type, 2024 and 2031 (USD Million)
- 11.4.10.3.1 South Africa: Human Cells Market, by Type, 2024 and 2031 (USD Million)
- 11.4.10.4 South Africa: Cell Therapy Instruments Market, by Process, 2024 and 2031 (USD Million)
- 11.4.10.5 South Africa: Cell Therapy Instruments Market, by End User, 2024 and 2031 (USD Million)
- 11.5 South and Central America: Cell Therapy Instruments Market
- 11.5.1 Overview
- 11.5.2 South and Central America: Cell Therapy Instruments Market - Revenue and Forecast to 2031 (US$ Million)
- 11.5.3 South and Central America: Cell Therapy Instruments Market, by Product, 2024 and 2031 (USD Millions)
- 11.5.3.1 South and Central America: Equipment Market, by Type, 2024 and 2031 (USD Millions)
- 11.5.4 South and Central America: Cell Therapy Instruments Market, by Cell Type, 2024 and 2031 (USD Million)
- 11.5.4.1 South and Central America: Human Cells Market, by Type, 2024 and 2031 (USD Million)
- 11.5.5 South and Central America: Cell Therapy Instruments Market, by Process, 2024 and 2031 (USD Million)
- 11.5.6 South and Central America: Cell Therapy Instruments Market, by End User, 2024 and 2031 (USD Million)
- 11.5.7 South and Central America: Cell Therapy Instruments Market, by Country, 2019 and 2031 (%)
- 11.5.8 Brazil: Cell Therapy Instruments Market and Revenue and Forecast to 2031 (USD Million)
- 11.5.8.1 Brazil: Cell Therapy Instruments Market and Revenue and Forecast to 2031 (USD Million)
- 11.5.8.2 Brazil: Cell Therapy Instruments Market, by Product, 2024 and 2031 (USD Millions)
- 11.5.8.2.1 Brazil: Equipment Market, by Type, 2024 and 2031 (USD Millions)
- 11.5.8.3 Brazil: Cell Therapy Instruments Market, by Cell Type, 2024 and 2031 (USD Million)
- 11.5.8.3.1 Brazil: Human Cells Market, by Type, 2024 and 2031 (USD Million)
- 11.5.8.4 Brazil: Cell Therapy Instruments Market, by Process, 2024 and 2031 (USD Million)
- 11.5.8.5 Brazil: Cell Therapy Instruments Market, by End User, 2024 and 2031 (USD Million)
- 11.5.9 Argentina: Cell Therapy Instruments Market and Revenue and Forecast to 2031 (USD Million)
- 11.5.9.1 Argentina: Cell Therapy Instruments Market and Revenue and Forecast to 2031 (USD Million)
- 11.5.9.2 Argentina: Cell Therapy Instruments Market, by Product, 2024 and 2031 (USD Millions)
- 11.5.9.2.1 Argentina: Equipment Market, by Type, 2024 and 2031 (USD Millions)
- 11.5.9.3 Argentina: Cell Therapy Instruments Market, by Cell Type, 2024 and 2031 (USD Million)
- 11.5.9.3.1 Argentina: Human Cells Market, by Type, 2024 and 2031 (USD Million)
- 11.5.9.4 Argentina: Cell Therapy Instruments Market, by Process, 2024 and 2031 (USD Million)
- 11.5.9.5 Argentina: Cell Therapy Instruments Market, by End User, 2024 and 2031 (USD Million)
12. Impact of COVID-19 Pandemic on Global Cell Therapy Instruments Market
- 12.1 North America: Impact Assessment of COVID-19 Pandemic
- 12.2 Europe: Impact Assessment of COVID-19 Pandemic
- 12.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic
- 12.4 Rest of the World: Impact Assessment of COVID-19 Pandemic
13. Industry Landscape
- 13.1 Overview
- 13.2 Growth Strategies Done by the Companies in the Market, (%)
- 13.3 Organic Developments
- 13.3.1 Overview
- 13.4 Inorganic Developments
- 13.4.1 Overview
14. Company Profiles
- 14.1 THERMO FISHER SCIENTIFIC INC.
- 14.1.1 Key Facts
- 14.1.2 Business Description
- 14.1.3 Products and Services
- 14.1.4 Financial Overview
- 14.1.5 SWOT Analysis
- 14.1.6 Key Developments
- 14.2 MERCK KGaA
- 14.2.1 Key Facts
- 14.2.2 Business Description
- 14.2.3 Products and Services
- 14.2.4 Financial Overview
- 14.2.5 SWOT Analysis
- 14.2.6 Key Developments
- 14.3 Lonza
- 14.3.1 Key Facts
- 14.3.2 Business Description
- 14.3.3 Products and Services
- 14.3.4 Financial Overview
- 14.3.5 SWOT Analysis
- 14.3.6 Key Developments
- 14.4 General Electric Company
- 14.4.1 Key Facts
- 14.4.2 Business Description
- 14.4.3 Products and Services
- 14.4.4 Financial Overview
- 14.4.5 SWOT Analysis
- 14.4.6 Key Developments
- 14.5 Terumo Corporation
- 14.5.1 Key Facts
- 14.5.2 Business Description
- 14.5.3 Products and Services
- 14.5.4 Financial Overview
- 14.5.5 SWOT Analysis
- 14.5.6 Key Developments
- 14.6 BD
- 14.6.1 Key Facts
- 14.6.2 Business Description
- 14.6.3 Products and Services
- 14.6.4 Financial Overview
- 14.6.5 SWOT Analysis
- 14.6.6 Key Developments
- 14.7 Miltenyi Biotec
- 14.7.1 Key Facts
- 14.7.2 Business Description
- 14.7.3 Products and Services
- 14.7.4 Financial Overview
- 14.7.5 SWOT Analysis
- 14.7.6 Key Developments
- 14.8 STEMCELL Technologies Inc.
- 14.8.1 Key Facts
- 14.8.2 Business Description
- 14.8.3 Products and Services
- 14.8.4 Financial Overview
- 14.8.5 SWOT Analysis
- 14.8.6 Key Developments
- 14.9 Sartorius AG
- 14.9.1 Key Facts
- 14.9.2 Business Description
- 14.9.3 Products and Services
- 14.9.4 Financial Overview
- 14.9.5 SWOT Analysis
- 14.9.6 Key Developments
- 14.10 Danaher (Beckman Coulter, Inc.)
- 14.10.1 Key Facts
- 14.10.2 Business Description
- 14.10.3 Products and Services
- 14.10.4 Financial Overview
- 14.10.5 SWOT Analysis
- 14.10.6 Key Developments
15. Appendix
- 15.1 Glossary of Terms
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.